Back to KROS
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP → KROS
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP KROS Position History
Keros Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$2M
Q3 2026
Peak value
$27.2M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $27.2M |
| Q1 2026 | $6.5M |
| Q2 2026 | $2.5M |
| Q3 2026 | $2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $2M | 172.7K | — | — |
| Q2 2026 | $2.5M | 233.2K | — | — |
| Q1 2026 | $6.5M | 590.2K | — | — |
| Q4 2025 | $27.2M | 1.33M | — | — |